Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay.
about
Clinically Available Medicines Demonstrating Anti-Toxoplasma ActivitySynergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosisEffectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeysIn vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondiiThe ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infectionVacuolar-type H+-ATPase regulates cytoplasmic pH in Toxoplasma gondii tachyzoites.Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycinLocalization of azithromycin in Toxoplasma gondii-infected cellsPharmacokinetics of spiramycin in the rhesus monkey: transplacental passage and distribution in tissue in the fetus.Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitisEffects of specific monoclonal antibodies to dense granular proteins on the invasion of Toxoplasma gondii in vitro and in vivo.Antiparasitic treatment suppresses production and avidity of Toxoplasma gondii-specific antibodies in a murine model of acute infection*.Inhibition of Toxoplasma gondii protein synthesis by azithromycin.Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.In vitro activity of the interaction between taxifolin (dihydroquercetin) and pyrimethamine against Toxoplasma gondii.Acidocalcisomes in Toxoplasma gondii tachyzoites.Vacuolar proton pyrophosphatase activity and pyrophosphate (PPi) in Toxoplasma gondii as possible chemotherapeutic targetsRespiration and oxidative phosphorylation in the apicomplexan parasite Toxoplasma gondii.In vitro antagonistic and indifferent activity of combination of 3-deoxyanthocyanidins against Toxoplasma gondii.Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France.Characterization of isolated acidocalcisomes from Toxoplasma gondii tachyzoites reveals a novel pool of hydrolyzable polyphosphate.
P2860
Q26782581-E891C43B-6AE1-44C4-98ED-0D17384FC351Q28326714-AD42D9BF-C838-49E1-B907-F68DD3B4BAEBQ28368237-0AFEA418-9D13-41E0-9B74-F397299B3D3DQ28378355-587EF4A3-DBC5-43AA-BC19-F0C66258D385Q28379168-A567AA86-EFC1-48D8-9333-A38BABC17180Q32109561-7EA9B9E0-110F-4963-A465-B1BD3327073AQ33746997-A340620E-DE5A-4BC9-B8FF-55A6086D2FDDQ33755229-81415AA1-20B3-4FC9-A92C-AAD75ED47642Q33757694-02D89EC0-5986-4EBC-B801-4170AA6FFA14Q35821124-F1BA9A13-5C75-4B0E-AF5F-FE322D9EEEFBQ37289850-F9A5E12D-A9F7-4556-8BE5-642DF239F588Q37531268-EB611BB6-7E7E-4B57-A1A2-A87EBD6844ECQ39866456-3E4D0A0C-9A5E-4C08-AE67-ADB878C9D3CFQ39883651-80F5FEFF-0EAE-477F-B959-0CD2E3A84798Q40139828-F4B8CFB7-AEE1-445C-911E-EFE8FA115097Q42126735-B287F895-73A8-4E94-80C5-E3C3C45280D5Q42238346-BD93FF8F-71A3-4AC8-BE8A-9A9E9452CB8CQ42463883-D4090FE7-92C8-45D9-AFF1-7AA0A6B0F78EQ43167893-8AADBDD4-465C-4494-9874-FC46FF9AC930Q43202341-D6DDA83A-89E9-4AF4-A72E-B590E045E66BQ43872712-D050C720-A56A-4C2E-AB73-38D2EB7BA5AEQ44179245-FD9AB3A0-ED4E-4BE9-B533-96D6AB191855
P2860
Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Comparative activity of macrol ...... ity of an in vitro microassay.
@en
type
label
Comparative activity of macrol ...... ity of an in vitro microassay.
@en
prefLabel
Comparative activity of macrol ...... ity of an in vitro microassay.
@en
P2093
P2860
P356
P1476
Comparative activity of macrol ...... ity of an in vitro microassay.
@en
P2093
Chamberland S
Current WL
P2860
P304
P356
10.1128/AAC.35.5.903
P407
P577
1991-05-01T00:00:00Z